Authors
Loading...
Mendelian randomization shows mitochondrial proteins COA3, NFU1, and SARS2 impact diabetic polyneuropathy risk, suggesting potential therapeutic targets.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: